Steven Reed, PhD, Founder of the Infectious Disease Research Institute
Steve Reed is IDRI’s Founder and Curevo’s Executive Advisor and Director. His academic appointments include Professor of Medicine at Cornell University Medical College in New York and Research Professor of Pathobiology at the University of Washington. He serves on several editorial review committees, has served as a member of the Tropical Medicine Review Board of the National Institutes of Health, and has served as a member of diagnostic and vaccine steering committees of the World Health Organization. Steve’s research interests have focused on the immunology of intracellular infections, and on the development of vaccines and diagnostics for both cancer and infectious diseases.
David Koelle, MD, University of Washington, Professor of Medicine, and Allergy and Infectious Disease
David Koelle, MD, is Professor in the Division of Allergy and Infectious Diseases at the University of Washington. His research focuses on the T cell immune response to viruses in the alphaherpesvirus family, including varicella zoster virus (VZV), the cause of shingles, as well as herpes simplex virus (HSV). Candidate HSV vaccines have been advanced through discovery, pre-clinical, and clinical stages of development. The laboratory also performs immune monitoring tests for specimens from vaccine clinical trials. Studies are sponsored by the US National Institutes of Health and by biotechnology and pharmaceutical companies. In addition to research, Dr. Koelle sees patients and assists with T cell-based diagnostic testing at the University of Washington.
Dr. Myron Levin, MD
Myron J. Levin, MD is a Professor of Pediatrics & Medicine at the University of Colorado School of Medicine (UCSOM) in the section of Pediatric Infectious Diseases and Epidemiology and is the Associate Director of the Pediatric HIV Clinic. He graduated from Harvard Medical School in 1960, and completed a residency in Internal Medicine at the Bronx Municipal hospital Center (Einstein Medical School). He spent the next three years at the National Institutes of Health; the last two years at NIH were devoted to research in molecular virology. He returned to Harvard in 1969 to complete a fellowship in Infectious Diseases, and remained as the first Chief of Infectious Diseases at the Sidney Farber Cancer Center (now the Dana-Farber Cancer Institute).
Dr. Soren Gantt
Dr. Gantt received his ScB from Brown University and then completed MD & PhD degrees at New York University, where he worked on malaria vaccine development. He then did Pediatrics Residency, Infectious Diseases Fellowship, and obtained an MPH degree, at University of Washington/Seattle Children’s Hospital, where he led studies of mother-child-transmission of HIV and human herpesviruses. Dr. Gantt was Head of Pediatric Infectious Diseases at University of British Columbia prior to moving to Université de Montréal, where he is currently the Director of Clinical Research at Centre Hospitalier Universitaire Sainte-Justine. His ongoing studies include identifying the correlates of protection against CMV and EBV infections in children, conducting CMV and VZV vaccine trials, and leading chemotherapy trials for Kaposi sarcoma .
Dr. Peter Gilbert
Peter Gilbert is a biostatistician whose research centers on design and analysis of randomized clinical trials for preventive vaccines against HIV and other pathogens including dengue, malaria, and herpes zoster. Dr. Gilbert received his PhD in biostatistics from the University of Washington in 1996, and following 5 years at Harvard Biostatistics, he has been at the Fred Hutchinson Cancer Research Center and University of Washington. Dr. Gilbert’s two main research activities over the past 20 years have been leadership for the Statistical Data Management Center of the HIV Vaccine Trials Network, and methodological and applied statistical research for evaluation of vaccine efficacy and evaluation of immunological/viral sequence correlates of vaccine efficacy.